Revenue
$67.7M
▲ 16.9% YoY
Net Income
-$412.7M
▲ 20.5% YoY
EPS
$-3.81
▲ 27.4% YoY
Cash
$155.5M
▼ 17.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
BASTA JAMES EVP, General Counsel | Sell | Mar 2, 2026 | 1.2K | $13.78 | $17K | Form 4 ↗ |
Clark Eliana EVP, Chief Technical Officer | Sell | Mar 2, 2026 | 607 | $13.78 | $8K | Form 4 ↗ |
LEONARD JOHN M President and CEO | Grant | Mar 1, 2026 | 156.4K | $0.00 | $0 | Form 4 ↗ |
BASTA JAMES EVP, General Counsel | Grant | Mar 1, 2026 | 46.1K | $0.00 | $0 | Form 4 ↗ |
Lebwohl David EVP, Chief Medical Officer | Grant | Mar 1, 2026 | 9.9K | $0.00 | $0 | Form 4 ↗ |
Dulac Edward J III EVP, Chief Financial Officer | Grant | Mar 1, 2026 | 61.3K | $0.00 | $0 | Form 4 ↗ |
Schultes Birgit C EVP, Chief Scientific Officer | Grant | Mar 1, 2026 | 39.2K | $0.00 | $0 | Form 4 ↗ |
Clark Eliana EVP, Chief Technical Officer | Grant | Mar 1, 2026 | 7.4K | $0.00 | $0 | Form 4 ↗ |
Dube Michael P VP, Chief Accounting Officer | Grant | Mar 1, 2026 | 17.3K | $0.00 | $0 | Form 4 ↗ |
LEONARD JOHN M President and CEO | Sell | Jan 5, 2026 | 34.1K | $9.21 | $314K | Form 4 ↗ |
Schultes Birgit C EVP, Chief Scientific Officer | Sell | Jan 5, 2026 | 8.5K | $9.21 | $78K | Form 4 ↗ |
BASTA JAMES EVP, General Counsel | Sell | Jan 5, 2026 | 10.4K | $9.21 | $96K | Form 4 ↗ |
Cohen Fred E Insider | Buy | Jan 5, 2026 | 150.0K | $9.35 | $1.40M | Form 4 ↗ |
Lebwohl David EVP, Chief Medical Officer | Sell | Jan 5, 2026 | 11.9K | $9.21 | $110K | Form 4 ↗ |